Pharmabiz

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents

US FDA approves Innoviva’s Nuzolvence, a first-in-class, single-dose, oral antibiotic to treat uncomplicated urogenital gonorrhoea in adults?and adolescents: Waltham, Massachuse ...
Pharmabiz

Greenspace Herbs opens US base as global demand surges for 'Quantum Ayurveda'

Greenspace Herbs, the Bengaluru-based company has opened a full-scale US office in New Jersey. The expansion comes as international supplement brands rush to secure a supply of the company's ...
Pharmabiz

MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community

MOC Cancer Care Centre hosts ONCO 3Sixty 2025 bringing together multi-oncology community: Our Bureau, Mumbai Monday, December 15, 2025, 17:40 Hrs [IST] MOC Cancer Care & Research ...
Pharmabiz

IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals

IHH Healthcare sets for next phase of growth in India with successful closure of the open offer for Fortis Healthcare and Fortis Malar Hospitals: Our Bureau, Bengaluru Monday, Dec ...
Pharmabiz

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation

University of Western Australia with AMTZ to position Visakhapatnam as a major Indo-Pacific hub for MedTech innovation: Our Bureau, Bengaluru Monday, December 15, 2025, 14:15 Hrs ...
Pharmabiz

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients

NIH clinical trial shows expanded umbilical cord blood transplant achieves 94% survival in severe aplastic anaemia patients: Maryland Monday, December 15, 2025, 15:00 Hrs [IST] A ...
Pharmabiz

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor

ICMR funds new clinical trial to test effective dosing strategy of high-cost cancer drug PARP inhibitor: Our Bureau, Mumbai Monday, December 15, 2025, 17:10 Hrs [IST] Funded by th ...
Pharmabiz

EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension

EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension: Rahway, New Jersey Monday, December 15, 2025, 1 ...
Pharmabiz

Ebekme with AHPI to set up Co-Skills Hub dedicated exclusively to hospital workforce training

Ebekme with AHPI to set up Co-Skills Hub dedicated exclusively to hospital workforce training: Our Bureau, Bengaluru Monday, December 15, 2025, 13:40 Hrs [IST] Ebekmed, in collabo ...
Pharmabiz

EMA committee recommends approval of STADA & Bio-Thera’s golimumab biosimilar Gotenfia

Thera’s golimumab biosimilar Gotenfia: Bad Vilbel, Germany Monday, December 15, 2025, 14:00 Hrs [IST] Global specialty, generic ...
Pharmabiz

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...
Pharmabiz

EMA recommends conditional marketing authorisation for Serum Life Science Europe’s Anktiva to treat non-muscle invasive bladder cancer

EMA recommends conditional marketing authorisation for Serum Life Science Europe’s Anktiva to treat non-muscle invasive bladder cancer: Amsterdam, The Netherland Monday, Decembe ...